Curasia Medilabs Enters High-Growth Tamil Nadu Market with Monopoly PCD Pharma Franchise Model
Tamil Nadu is one of the most prospective pharmaceutical and healthcare markets in India. It has a highly developed healthcare system, increased medical knowledge, and a growing need for branded medicines of ethical origin. With its monopoly-based PCD franchise system in the state, Curasia Medilabs intends to establish a strong regional presence and provide partners with complete territorial exclusivity. - February 04, 2026
Curasia Medilabs Private Limited Offers Monopoly-Based PCD Pharma Franchise Opportunities
Curasia Medilabs Private Limited announces monopoly-based PCD pharma franchise opportunities, offering exclusive territories, a diversified product range, and structured partner support across India. - December 27, 2025
Press Releases 1 - 2 of 2